August 12, 2025

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Healthcare Innovator with 23.72% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, is capturing investor attention with its innovative approach to spinal disorder treatments and an impressive 23.72% potential upside...

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Unpacking a 58.93% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing the attention of investors with an impressive potential upside of 58.93%, as indicated by current analyst ratings. This biotechnology company, headquartered in..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 39% Potential Upside with Robust Revenue Growth

Veracyte, Inc. (VCYT) has become an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.2 billion, Veracyte is making waves..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring Over 130% Potential Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands as a compelling entity in the biotechnology sector, focusing intently on developing therapeutics for neurodegenerative and lysosomal storage diseases. With a market capitalization of..

Kymera Therapeutics (KYMR) Stock Report: Biotechnology Firm Offers 60% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a cutting-edge biotechnology firm headquartered in Watertown, Massachusetts, is captivating investor attention with its innovative approach to drug development and a notable potential upside of..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 105% Upside in the Biosimilars Market

Alvotech (ALVO), a dynamic player in the healthcare sector, specifically in the drug manufacturing industry for specialty and generic medications, has been capturing investor interest with its promising portfolio of..

Progyny, Inc. (PGNY) Stock Analysis: Exploring the 27.59% Potential Upside for Investors

Investors keen on healthcare opportunities may find Progyny, Inc. (NASDAQ: PGNY) an intriguing prospect in the fast-growing fertility and family-building benefits sector. With a market capitalization of $1.87 billion, Progyny..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech Player with 18.83% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a burgeoning name in the biotechnology sector, headquartered in Foster City, California. With a focused mission on developing novel therapies for rare and orphan..

Xenon Pharmaceuticals (XENE) Stock Analysis: A 61% Potential Upside in Neuroscience Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian-based biopharmaceutical company, is generating buzz among investors, particularly those interested in the rapidly evolving field of neuroscience. With a market capitalization of $2.62..

Ascentage Pharma Group Internat (AAPG): Analyzing Growth Potential Amidst a 97.9% Revenue Surge

Ascentage Pharma Group International (AAPG) is garnering significant attention in the biotechnology sector with its impressive 97.9% revenue growth. This clinical-stage biotechnology company, headquartered in Suzhou, China, is focused on..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 52% Upside Potential in Biotech

Investors with a keen interest in the biotechnology sector may want to pay close attention to Vericel Corporation (NASDAQ: VCEL), a commercial-stage biopharmaceutical company that specializes in cellular therapies and..

NovoCure Limited (NVCR): Potential 149% Upside Awaits Investors in the Medical Device Innovator

As the healthcare sector continues to evolve, NovoCure Limited (NASDAQ: NVCR) stands out as a company at the forefront of medical innovation. Specializing in oncology solutions, NovoCure’s work in developing..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 23.43% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a leading provider in the healthcare sector, is capturing investor attention with its strong growth potential and a significant upside in its stock price. With..

PTC Therapeutics, Inc. (PTCT)

⚠️ No article content returned.

..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth in the Dental Market with a 6.23% Potential Upside

Envista Holdings Corporation (NYSE: NVST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista focuses on developing,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring Potential Upside with Gene Editing Innovations

CRISPR Therapeutics AG (CRSP), a pioneer in gene-editing technology, stands at the forefront of the biotechnology industry with its cutting-edge CRISPR/Cas9 platform. With a market capitalization of $5.04 billion, the..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Unveiling a 29.73% Potential Upside

For investors eyeing the biotechnology sector, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity, driven by its advanced pipeline of innovative peptide therapeutics and a promising projected upside of..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking a 49.87% Potential Upside

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector, is drawing investor attention, not just for its innovative medical technologies but also for its compelling stock performance potential...

Arrowhead Pharmaceuticals (ARWR): Biotech’s Hidden Gem with a 154% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is emerging as a captivating prospect within the biotech sector, promising significant growth potential for investors with its current price of $17.21 and a striking..

Privia Health Group, Inc. (PRVA): Analyst Consensus Suggests a 47.71% Upside Potential

Investors looking into the healthcare sector might want to pay close attention to Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the health information services industry. With a..

Search

Funds

August 12, 2025

Search

Funds

August 12, 2025

FTSE 100

Funds